Posted by: Audrey Erbes | May 5, 2013

Political Influence on FDA Approvals Unhealthy Plus Events and Jobs

Politics and FDA Approval of Drugs

Politics and contraception is once again an issue in the news. Many are shocked about the disagreements of the FDA with a recent court ruling about the age at which women can purchase over-the-counter “morning after” contraceptive pills—FDA will accept lowering the age from 17 to 15 years vs. the court ruling that females of any age should be able to purchase them. There are those for and against the lowering of the age. Some are against availability of the product without a prescription at all.

Unfortunately, approval of drugs by the FDA is impacted by public opinion and lobbying groups when it comes to female reproductive medicine. I find the FDA’s concern about proper usage of the pill by teenagers worthy of consideration based on efficacy and safety reasons warranted but not if it’s a reaction to outside pressure rather than based on scientific and medical grounds.  Here’s another viewpoint in favor of eliminating age requirement.

Bay Area Events This Upcoming Week

  • BioCentury This Week, See new program Webcast Starting Sunday, May 5, 2013, Available anytime starting at 9:00 a.m. EDT; Topic: “Affordable Innovation: Tower of Babble;” Speakers: Join BioCentury Washington Editor Steve Usdin and Avalere Health CEO Dan Mendelson in this second program on “Affordable Innovation,” joined by: Tony Coelho, former member of Congress from California and primary sponsor of the Americans with Disabilities Act, who now works as an advocate for patients with epilepsy and other diseases and Scott Gottlieb, former deputy commissioner of FDA and now Resident Fellow of the American Enterprise Institute.
  • NCC AWIS, Monday Evening, May 6, 2013; Event: “19th Annual Awards Banquet”
  • Bio2Device Group, Tuesday Morning, May 7, 2013; Topic: “Occupational Therapy Devices;” Speaker: Anupam Pathak, CEO, Founder, Lift Labs
  • WIB-San Francisco Bay Area, Tuesday Evening, May 7, 2013; Topic:  “Funding your Idea: Growing From Concept to Reality”
  • San Francisco AWIS, Wednesday Evening, May 8, 2013; Event: “Maximize your membership: Volunteer with sfAWIS! “
  • BayBio, Thursday Evening, May 9, 2013; Event: “BayBio Spring Mixer and Open House”

Next Upcoming UC Berkeley Extension Business and Marketing Course

  • UC Berkeley Extension Intensive Course, Thursday and Friday, June 20-21, 2013; Course: “Life Science Business Development;” Instructor: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and blog; Guest Speakers: Bill McMillan, CSO, founder and owner of Profusa, Inc.; Harold (Hal) Etterman, MBA, CEO, Knight Financial Plans & Services, LLC; Carolyn Feamster, MBA, a business strategy and analysis consultant; Gilbert R. Mintz, Ph.D., President of GRM Associates; Ginger Dreger, J.D., M.S., partner in Arnold & Porter LLP; and Chris Dokomajilar, Manager, Senior Biopharma Analyst at Deloitte Recap LLC; Dates and Time: Thursday and Friday, June 20-21, 2013; 8:30 am – 5:00 pm for classroom intensive and balance of term for working on term project; Location: Downtown University of California, Berkeley Extension, 425 Market St., 8th Floor, San Francisco, CA 94105; Fee: $895, (EDP 405118). Register at

You can download the list of events from May through June—Audreys picks May 5, 2013—as well as the list of Jobs That Crossed My Desk Through May 5 for the past three weeks by right clicking on the highlighted titles. You can also find all my blogs and lists on my blog at

You can find me at the Bio2Device Group meeting on Tuesday morning.



  1. Audrey, thanks so much for the link!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: